Taken together, these findings demonstrate that ASCL1 and OLIG2 are differentially dysregulated by the loss of Tp53, Nf1, and Pten at early stages (P30), but these transcription factors can reciprocally and positively regulate or influence the other’s expression within growing brain tumors. The gene discussed is ASCL1; the disease is brain neoplasm.